# Albert Hagège

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/albert-hagege/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,301 |
| Field | Cardiomyopathy and Myosin Studies |
| h-index | 73 |
| i10-index | 169 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5056456796 |
| ORCID iD | https://orcid.org/0000-0003-4685-6077 |
| Works | 404 |

## Researcher papers

Showing 12 of 13.

- [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy](https://scholariq.org/papers/2014-esc-guidelines-on-diagnosis-and-management-of-hypertrophic-cardiomyopathy/)
- [Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy/)
- [Myoblast transplantation for heart failure](https://scholariq.org/papers/myoblast-transplantation-for-heart-failure/)
- [Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction](https://scholariq.org/papers/autologous-skeletal-myoblast-transplantation-for-severe-postinfarction-left/)
- [The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial](https://scholariq.org/papers/the-myoblast-autologous-grafting-in-ischemic-cardiomyopathy-magic-trial/)
- [Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure](https://scholariq.org/papers/angiotensin-receptor-neprilysin-inhibition-compared-with-enalapril-on-the-risk/)
- [Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction](https://scholariq.org/papers/transplantation-of-human-embryonic-stem-cell-derived-cardiovascular-progenitors/)
- [Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1](https://scholariq.org/papers/human-embryonic-stem-cell-derived-cardiac-progenitors-for-severe-heart-failure/)
- [A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates](https://scholariq.org/papers/a-purified-population-of-multipotent-cardiovascular-progenitors-derived-from/)
- [Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function](https://scholariq.org/papers/comparison-of-the-effects-of-fetal-cardiomyocyte-and-skeletal-myoblast/)
- [Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study](https://scholariq.org/papers/transplantation-of-cardiac-committed-mouse-embryonic-stem-cells-to-infarcted/)
- [Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies](https://scholariq.org/papers/development-and-validation-of-a-new-risk-prediction-score-for-life-threatening/)

## Researcher topics

- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Cardiac Structural Anomalies and Repair](https://scholariq.org/topics/cardiac-structural-anomalies-and-repair/)
- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.